WO2008146085A3 - Inflammation and oxidative stress reducing composition for topical or oral administration - Google Patents
Inflammation and oxidative stress reducing composition for topical or oral administration Download PDFInfo
- Publication number
- WO2008146085A3 WO2008146085A3 PCT/IB2007/004618 IB2007004618W WO2008146085A3 WO 2008146085 A3 WO2008146085 A3 WO 2008146085A3 IB 2007004618 W IB2007004618 W IB 2007004618W WO 2008146085 A3 WO2008146085 A3 WO 2008146085A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topical
- inflammation
- oral administration
- oxidative stress
- reducing composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00387—Plasters use skin protection
- A61F2013/00391—Plasters use skin protection from irradiation, e.g. sun
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
The invention provides, in one embodiment, a method for making lecithin phospholipid with lipoic or piperic acid based composition, a preparation for use as a topical skin application for treatment of infectious skin lesions such as acne, for the protection of skin cells from oxidative agents, and as anti-inflammatory treatments.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81732606P | 2006-06-28 | 2006-06-28 | |
US60/817,326 | 2006-06-28 | ||
US58086606P | 2006-10-10 | 2006-10-10 | |
US60/580,866 | 2006-10-10 | ||
US11/770,390 | 2007-06-28 | ||
US11/770,390 US20080003244A1 (en) | 2006-06-28 | 2007-06-28 | Inflammation and Oxidative Stress Reducing Compostion for Topical or Oral Administration |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008146085A2 WO2008146085A2 (en) | 2008-12-04 |
WO2008146085A3 true WO2008146085A3 (en) | 2009-01-29 |
Family
ID=39998950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/004618 WO2008146085A2 (en) | 2006-06-28 | 2007-06-28 | Inflammation and oxidative stress reducing composition for topical or oral administration |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008146085A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102012078B1 (en) * | 2017-08-02 | 2019-08-19 | 포항공과대학교 산학협력단 | An anti-aging or skin regenerating composition comprising piperonylic acid as an active ingredient |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265345A1 (en) * | 2003-06-30 | 2004-12-30 | Perricone Nicholas V. | Treatment of skin damage using acetyl carnitine and lipoic acid |
WO2006015774A1 (en) * | 2004-08-06 | 2006-02-16 | Bioghurt Biogarde Gmbh & Co. Kg | Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide |
JP2006248904A (en) * | 2005-03-08 | 2006-09-21 | Yoshihiro Futamura | ANTI-INFLAMMATORY AGENT COMPOSED OF CONJUGATE OF alpha-LIPOIC ACID AND POLYVALENT UNSATURATED FATTY ACID AND EXHIBITING FREE RADICAL SCAVENGING ACTION, FOOD FORMULATION AND COSMETIC FORMULATION COMPRISING THE SAME |
-
2007
- 2007-06-28 WO PCT/IB2007/004618 patent/WO2008146085A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265345A1 (en) * | 2003-06-30 | 2004-12-30 | Perricone Nicholas V. | Treatment of skin damage using acetyl carnitine and lipoic acid |
WO2006015774A1 (en) * | 2004-08-06 | 2006-02-16 | Bioghurt Biogarde Gmbh & Co. Kg | Physiologically acceptable composition containing alpha-lipoic acid, creatine, and a phosphatide |
JP2006248904A (en) * | 2005-03-08 | 2006-09-21 | Yoshihiro Futamura | ANTI-INFLAMMATORY AGENT COMPOSED OF CONJUGATE OF alpha-LIPOIC ACID AND POLYVALENT UNSATURATED FATTY ACID AND EXHIBITING FREE RADICAL SCAVENGING ACTION, FOOD FORMULATION AND COSMETIC FORMULATION COMPRISING THE SAME |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Week 200724, Derwent World Patents Index; AN 2007-234399, XP002505043 * |
PERRICONE ET AL: "Topical 5% alpha lipoic acid cream in the treatment of cutaneous rhytids", AESTHETIC SURGERY JOURNAL, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, vol. 20, no. 3, 1 May 2000 (2000-05-01), pages 218 - 222, XP005701142, ISSN: 1090-820X * |
Also Published As
Publication number | Publication date |
---|---|
WO2008146085A2 (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010070675A3 (en) | Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof | |
WO2007129270A3 (en) | Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle | |
WO2008139122A3 (en) | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same | |
UA88464C2 (en) | Method of topical methadone administration providing systemic effect | |
WO2008022256A3 (en) | Methods and compositions for preventing or treating age-related diseases | |
WO2008070116A3 (en) | Topical compositions for treatment of skin conditions | |
WO2008052044A3 (en) | Use of derivatives of propofol for treating diseases associated with oxidative stress | |
WO2010062581A3 (en) | A botanical composition for enhanced skin repair and uses thereof | |
WO2005079143A3 (en) | Topical formulations for the treatment of skin conditions | |
WO2007092755A3 (en) | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 | |
WO2010009892A3 (en) | Compositions for the treatment of pain and/or inflamation | |
WO2008070368A3 (en) | Methods and compositions for skin care | |
WO2009049184A9 (en) | Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors | |
WO2009040420A3 (en) | Use of a monoterpene to increase tissue repair | |
WO2010121177A3 (en) | Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses | |
WO2006055352A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally | |
PL2465493T3 (en) | Topical compositions for the prevention and treatment of irritation of mucous cells | |
WO2008086457A3 (en) | Oral care compositions comprising a hippophae extract | |
WO2008042944A3 (en) | Non-irritating oral care formulations | |
WO2008070859A3 (en) | Treatment of skin conditions by dickkopf1 (dkk1) | |
WO2009022338A3 (en) | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
WO2008079993A3 (en) | Combinations of nitric oxide and sulfide and methods of use and manufacture thereof | |
WO2008107092A3 (en) | Use of derivatives of 4-hydroxyphenoxy acetic acid | |
WO2007056236A3 (en) | Methods of treating cancer with lipid-based platinum compound formulations administered intravenously | |
WO2008139123A3 (en) | Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07874543 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07874543 Country of ref document: EP Kind code of ref document: A2 |